A BILL 
To facilitate responsible, informed dispensing of controlled 
substances and other prescribed medications, and for 
other purposes. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. SHORT TITLE. 
3
This Act may be cited as the ‘‘Opioid Prescription 
4
Verification Act of 2021’’. 
5
01:52 May 26, 2021
H2355
2 
•HR 2355 IH
SEC. 2. MATERIALS FOR TRAINING PHARMACISTS ON CER-
1
TAIN 
CIRCUMSTANCES 
UNDER 
WHICH 
A 
2
PHARMACIST MAY DECLINE TO FILL A PRE-
3
SCRIPTION. 
4
(a) UPDATES TO MATERIALS.—Section 3212(a) of 
5
the SUPPORT for Patients and Communities Act (Public 
6
Law 115–271) is amended by striking ‘‘Not later than 1 
7
year after the date of enactment of this Act, the Secretary 
8
of Health and Human Services, in consultation with the 
9
Administrator of the Drug Enforcement Administration, 
10
Commissioner of Food and Drugs, Director of the Centers 
11
for Disease Control and Prevention, and Assistant Sec-
12
retary for Mental Health and Substance Use, shall develop 
13
and disseminate’’ and inserting ‘‘The Secretary of Health 
14
and Human Services, in consultation with the Adminis-
15
trator of the Drug Enforcement Administration, Commis-
16
sioner of Food and Drugs, Director of the Centers for Dis-
17
ease Control and Prevention, and Assistant Secretary for 
18
Mental Health and Substance Use, shall develop and dis-
19
seminate not later than 1 year after the date of enactment 
20
of this Act, and update periodically thereafter’’. 
21
(b) MATERIALS INCLUDED.—Section 3212(b) of the 
22
SUPPORT for Patients and Communities Act (Public 
23
Law 115–271) is amended— 
24
(1) by redesignating paragraphs (1) and (2) as 
25
paragraphs (2) and (3), respectively; and 
26
01:52 May 26, 2021
H2355
3 
•HR 2355 IH
(2) by inserting before paragraph (2), as so re-
1
designated, the following new paragraph: 
2
‘‘(1) pharmacists on how to verify the identity 
3
of individuals picking up prescriptions;’’. 
4
(c) MATERIALS FOR TRAINING ON VERIFICATION OF 
5
IDENTITY.—Section 3212 of the SUPPORT for Patients 
6
and Communities Act (Public Law 115–271) is amended 
7
by adding at the end the following new subsection: 
8
‘‘(d) MATERIALS FOR TRAINING ON VERIFICATION 
9
OF IDENTITY OF INDIVIDUALS PICKING UP PRESCRIBED 
10
MEDICATIONS.—Not later than 6 months after the date 
11
of enactment of this subsection, the Secretary of Health 
12
and Human Services, after seeking stakeholder input in 
13
accordance with subsection (c), shall— 
14
‘‘(1) update the materials developed under sub-
15
section (a) to include information for pharmacists on 
16
how to verify the identity of individuals picking up 
17
prescribed medications; and 
18
‘‘(2) disseminate, as appropriate, the updated 
19
materials.’’. 
20
SEC. 3. INCENTIVIZING STATES TO FACILITATE RESPON-
21
SIBLE, 
INFORMED 
DISPENSING 
OF 
CON-
22
TROLLED SUBSTANCES. 
23
(a) IN GENERAL.—Section 392A of the Public 
24
Health Service Act (42 U.S.C. 280b–1) is amended— 
25
01:52 May 26, 2021
H2355
4 
•HR 2355 IH
(1) by redesignating subsections (c) and (d) as 
1
subsections (d) and (e), respectively; and 
2
(2) by inserting after subsection (b) the fol-
3
lowing new subsection: 
4
‘‘(c) PREFERENCE.—In determining the amounts of 
5
grants awarded to States under subsections (a) and (b), 
6
the Director of the Centers for Disease Control and Pre-
7
vention may give preference to States in accordance with 
8
such criteria as the Director may specify and may choose 
9
to give preference to States that— 
10
‘‘(1) maintain a prescription drug monitoring 
11
program; 
12
‘‘(2) require dispensers of controlled substances 
13
in schedule II, III, or IV to verify the identity of the 
14
person who picks up a prescribed medication by re-
15
quiring such person to present a photo identification 
16
card that is valid as determined by the respective 
17
State; and 
18
‘‘(3) require dispensers of such controlled sub-
19
stances to enter certain information about the pur-
20
chase of such controlled substances into the respec-
21
tive State’s prescription drug monitoring program, 
22
including— 
23
01:52 May 26, 2021
H2355
5 
•HR 2355 IH
‘‘(A) the National Drug Code or, in the 
1
case of compounded medications, compound 
2
identifier; 
3
‘‘(B) the quantity dispensed; 
4
‘‘(C) the name of the patient; 
5
‘‘(D) the name of the ultimate user; 
6
‘‘(E) the name of the person who picks up 
7
the controlled substance, if different from the 
8
patient and ultimate user; and 
9
‘‘(F) the date filled.’’. 
10
(b) DEFINITIONS.—Subsection (d) of section 392A of 
11
the Public Health Service Act (42 U.S.C. 280b–1), as re-
12
designated by subsection (a)(1), is amended to read as fol-
13
lows: 
14
‘‘(d) DEFINITIONS.—In this section: 
15
‘‘(1) CONTROLLED
SUBSTANCE.—The term 
16
‘controlled substance’ has the meaning given that 
17
term in section 102 of the Controlled Substances. 
18
‘‘(2) DISPENSER.—The term ‘dispenser’ means 
19
a physician, pharmacist, or other person that dis-
20
penses a controlled substance to an ultimate user. 
21
‘‘(3) INDIAN TRIBE.—The term ‘Indian tribe’ 
22
has the meaning given that term in section 4 of the 
23
Indian Self-Determination and Education Assistance 
24
Act. 
25
01:52 May 26, 2021
H2355
6 
•HR 2355 IH
‘‘(4) STATE.—The term ‘State’ means each of 
1
the 50 States, the District of Columbia, and any 
2
commonwealth or territory of the United States. 
3
‘‘(5) ULTIMATE
USER.—The term ‘ultimate 
4
user’ means a person who has obtained from a dis-
5
penser, and who possesses, a controlled substance 
6
for the person’s own use, for the use of a member 
7
of the person’s household, or for the use of an ani-
8
mal.’’. 
9
Æ 
01:52 May 26, 2021
H2355
